FDA Inspection 1300034 — South Florida Institute For Reproductive Medicine, P.A.

South Florida Institute For Reproductive Medicine, P.A. — FEI 3003926766

The FDA completed an inspection of South Florida Institute For Reproductive Medicine, P.A. on January 22, 2026 in South Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 22, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
South Miami, FL (United States)